Table 2.
Individual patient characteristics of LyP patients with an associated MF
| No | Sex | Age | Time interval (months)† | Stage‡ | Treatment MF | Current status (follow‐up in months) | |
|---|---|---|---|---|---|---|---|
| MF | LyP | ||||||
| 1. | M | 58 | A (52) | IA | PUVA | Do (232) | Do (284) |
| 2. | F | 71 | B (3) | IB | PUVA | A+ (326) | A+ (323) |
| 3. | F | 56 | B (72) | IB | PUVA | Do (409) | Do (337) |
| 4. | F | 59 | A (274) | IA | Expectative | Do (57) | Do (331) |
| 5. | M | 44 | C | IA | Expectative | Do (177) | Do (177) |
| 6. | F | 87 | C | IB | PUVA | Do (23) | Do (23) |
| 7. | M | 80 | A (97) | IB | UVB | Do (13) | Do (110) |
| 8. | M | 58 | B (148) | IB | RT | Ao (225) | A+ (77) |
| 9. | M | 64 | B (91) | IB | UVB | Do (163) | Do (72) |
| 10. | M | 66 | A (24) | IA | UVB | Ao (178) | Ao (202) |
| 11. | F | 55 | B (208) | IA | Expectative | Ao (236) | A+ (28) |
| 12. | M | 51 | C | IA | PUVA | A+ (42) | A+ (42) |
| 13. | M | 70 | B (143) | IB | PUVA | A+ (261) | A+ (118) |
| 14. | M | 56 | A (144) | IB | UVB | A+ (92) | A+ (236) |
| 15. | M | 62 | A (50) | IA | Expectative | A+ (107) | Ao (157) |
| 16. | F | 64 | C | IA | Expectative | Do (87) | Do (87) |
| 17. | M | 42 | A (108) | IA | Expectative | Ao (15) | A+ (123) |
| 18. | M | 37 | C | IA | Expectative | A+ (124) | A+ (124) |
| 19. | M | 43 | C | IA | UVB | A+ (129) | Ao (129) |
| 20. | M | 54 | A (71) | IA | Expectative | A+ (31) | A+ (102) |
| 21. | M | 51 | A (36) | IA | Expectative | A+ (49) | A+ (85) |
| 22. | M | 69 | C | IA | Expectative | A+ (76) | A+ (76) |
| 23. | M | 48 | B (18) | IA | Expectative | Ao (67) | Ao (49) |
| 24. | F | 30 | A (34) | IA | Expectative | A+ (24) | A+ (58) |
| 25. | M | 35 | A (48) | IA | Expectative | A+ (10) | A+ (58) |
| 26. | F | 49 | C | IB | UVB | A+ (41) | A+ (41) |
| 27. | M | 50 | C | IA | Expectative | A+ (41) | Ao (41) |
| 28. | M | 36 | C | IA | Expectative | A+ (24) | A+ (24) |
| 29. | F | 77 | C | IA | Expectative | A+ (12) | A+ (12) |
| 30. | M | 65 | C | IA | Expectative | Ao (16) | A+ (16) |
| 31. | M | 53 | C | IA | Expectative | A+ (14) | A+ (14) |
†Associated lymphoma before (B) concomitant with (C) or after (A) diagnosis of lymphomatoid papulosis. ‡IA, patches/plaques <10% body surface. IB, patches/plaques >10% body surface.
A+, alive with disease; Ao, alive no evidence of disease; Do, died of unrelated disease; LyP, lymphomatoid papulosis; MF, mycosis fungoides; RT, radiotherapy.